Sanuwave Health FY2025 EPS Estimate Boosted by Roth Capital

Sanuwave Health Inc. (NASDAQ:SNWV) – Research analysts at Roth Capital increased their FY2025 earnings per share (EPS) estimates for Sanuwave Health in a report issued on Sunday, September 28th. Roth Capital analyst K. Bauser now anticipates that the company will post earnings of $0.42 per share for the year, up from their prior forecast of $0.26. Roth Capital has a “Buy” rating and a $55.00 price objective on the stock. Roth Capital also issued estimates for Sanuwave Health’s Q4 2025 earnings at $0.37 EPS, Q1 2026 earnings at $0.17 EPS, Q2 2026 earnings at $0.30 EPS, Q3 2026 earnings at $0.44 EPS, Q4 2026 earnings at $0.59 EPS, FY2026 earnings at $1.50 EPS and FY2027 earnings at $2.34 EPS.

Sanuwave Health (NASDAQ:SNWV) last issued its earnings results on Friday, August 8th. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.10. The company had revenue of $10.16 million during the quarter, compared to analyst estimates of $10.14 million. Sanuwave Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.

A number of other research firms have also recently weighed in on SNWV. Northland Securities started coverage on Sanuwave Health in a report on Wednesday, September 3rd. They set an “outperform” rating and a $55.00 price target on the stock. Northland Capmk raised Sanuwave Health to a “strong-buy” rating in a report on Wednesday, September 3rd. Finally, Wall Street Zen cut Sanuwave Health from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. One analyst has rated the stock with a Strong Buy rating and two have issued a Buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $55.00.

Sanuwave Health Trading Down 0.1%

SNWV opened at $37.43 on Wednesday. The business’s 50 day moving average is $37.75 and its 200-day moving average is $33.82. The stock has a market cap of $320.78 million, a PE ratio of -4.54 and a beta of 1.33. Sanuwave Health has a twelve month low of $5.63 and a twelve month high of $46.58.

Institutional Investors Weigh In On Sanuwave Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Legal & General Group Plc bought a new stake in Sanuwave Health during the second quarter worth approximately $26,000. Strategic Investment Solutions Inc. IL acquired a new position in Sanuwave Health in the first quarter worth approximately $47,000. BNP Paribas Financial Markets acquired a new position in Sanuwave Health in the second quarter worth approximately $46,000. Police & Firemen s Retirement System of New Jersey acquired a new position in Sanuwave Health in the second quarter worth approximately $52,000. Finally, New York State Common Retirement Fund acquired a new position in Sanuwave Health in the second quarter worth approximately $102,000. Institutional investors own 42.53% of the company’s stock.

Sanuwave Health Company Profile

SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.